Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. Reports Global Markets Directís wide variety of reports offer a targeted solution for marketing and strategic planning.

Sort by


Hyperalgesia - Pipeline Review, H2 2016

13 Jul 2016  |  Published by:  Global Markets Direct
Summary'Hyperalgesia - Pipeline Review, H2 2016', provides an overview of the Hyperalgesia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hyperalgesia, complete with analysis by stage of development, drug target, mechanism of action (MoA),...
$ 2,000.00 Read More

Cerebral Palsy - Pipeline Review, H2 2016

13 Jul 2016  |  Published by:  Global Markets Direct
Summary'Cerebral Palsy - Pipeline Review, H2 2016', provides an overview of the Cerebral Palsy pipeline landscape. The report provides comprehensive information on the therapeutics under development for Cerebral Palsy, complete with analysis by stage of development, drug target, mechanism of action ...
$ 2,000.00 Read More

Smallpox - Pipeline Review, H2 2016

13 Jul 2016  |  Published by:  Global Markets Direct
Summary'Smallpox - Pipeline Review, H2 2016', provides an overview of the Smallpox pipeline landscape. The report provides comprehensive information on the therapeutics under development for Smallpox, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of ad...
$ 2,000.00 Read More

Fatigue - Pipeline Review, H2 2016

13 Jul 2016  |  Published by:  Global Markets Direct
Summary'Fatigue - Pipeline Review, H2 2016', provides an overview of the Fatigue pipeline landscape. The report provides comprehensive information on the therapeutics under development for Fatigue, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of admin...
$ 2,000.00 Read More

RXi Pharmaceuticals Corporation - Product Pipeline Review - 2016

13 Jul 2016  |  Published by:  Global Markets Direct
Summary'RXi Pharmaceuticals Corporation - Product Pipeline Review - 2016', provides an overview of the RXi Pharmaceuticals Corporation's pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by RXi Pharmaceuticals Corporati...
$ 1,500.00 Read More

Post-Operative Pain - Pipeline Review, H2 2016

13 Jul 2016  |  Published by:  Global Markets Direct
Summary'Post-Operative Pain - Pipeline Review, H2 2016', provides an overview of the Post-Operative Pain pipeline landscape. The report provides comprehensive information on the therapeutics under development for Post-Operative Pain, complete with analysis by stage of development, drug target, mecha...
$ 2,000.00 Read More

Bacterial Vaginosis - Pipeline Review, H2 2016

13 Jul 2016  |  Published by:  Global Markets Direct
Summary'Bacterial Vaginosis - Pipeline Review, H2 2016', provides an overview of the Bacterial Vaginosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Bacterial Vaginosis, complete with analysis by stage of development, drug target, mecha...
$ 2,000.00 Read More

Phenylketonuria (PKU) - Pipeline Review, H2 2016

13 Jul 2016  |  Published by:  Global Markets Direct
Summary'Phenylketonuria (PKU) - Pipeline Review, H2 2016', provides an overview of the Phenylketonuria (PKU) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Phenylketonuria (PKU), complete with analysis by stage of development, drug target,...
$ 2,000.00 Read More

Charcot-Marie-Tooth Disease - Pipeline Review, H2 2016

13 Jul 2016  |  Published by:  Global Markets Direct
Summary'Charcot-Marie-Tooth Disease - Pipeline Review, H2 2016', provides an overview of the Charcot-Marie-Tooth Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development for Charcot-Marie-Tooth Disease, complete with analysis by stage of develop...
$ 2,000.00 Read More

Nerve Injury - Pipeline Review, H2 2016

13 Jul 2016  |  Published by:  Global Markets Direct
Summary'Nerve Injury - Pipeline Review, H2 2016', provides an overview of the Nerve Injury pipeline landscape. The report provides comprehensive information on the therapeutics under development for Nerve Injury, complete with analysis by stage of development, drug target, mechanism of action (MoA),...
$ 2,000.00 Read More

Hidradenitis Suppurativa - Pipeline Review, H2 2016

13 Jul 2016  |  Published by:  Global Markets Direct
Summary'Hidradenitis Suppurativa - Pipeline Review, H2 2016', provides an overview of the Hidradenitis Suppurativa pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hidradenitis Suppurativa, complete with analysis by stage of development, dru...
$ 2,000.00 Read More

Hepatic Encephalopathy - Pipeline Review, H2 2016

13 Jul 2016  |  Published by:  Global Markets Direct
Summary'Hepatic Encephalopathy - Pipeline Review, H2 2016', provides an overview of the Hepatic Encephalopathy pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hepatic Encephalopathy, complete with analysis by stage of development, drug targ...
$ 2,000.00 Read More

Nocturia - Pipeline Review, H2 2016

13 Jul 2016  |  Published by:  Global Markets Direct
Summary'Nocturia - Pipeline Review, H2 2016', provides an overview of the Nocturia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Nocturia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of ad...
$ 2,000.00 Read More

Galapagos NV - Product Pipeline Review - 2016

13 Jul 2016  |  Published by:  Global Markets Direct
Summary'Galapagos NV - Product Pipeline Review - 2016', provides an overview of the Galapagos NV's pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by Galapagos NV, complete with analysis by stage of development, drug ...
$ 1,500.00 Read More

Intermittent Claudication - Pipeline Review, H2 2016

13 Jul 2016  |  Published by:  Global Markets Direct
Summary'Intermittent Claudication - Pipeline Review, H2 2016', provides an overview of the Intermittent Claudication pipeline landscape. The report provides comprehensive information on the therapeutics under development for Intermittent Claudication, complete with analysis by stage of development, ...
$ 2,000.00 Read More
Total 3090 records.